Submissions are due on or before January 31, 2022 via the Submission Form
We encourage pre-submitting by sending entries by December 15, 2021 to receive feedback and the opportunity to resubmit ahead of the final deadline
Submissions must be brief and clear. They should be submitted as a PDF no longer than three pages, plus any appendices or citations an applicant deems relevant. Applicants are encouraged to review the Case Examples section before making a submission
All submitted ideas will remain confidential and the property of the applicant and/or their institution
Judging Criteria
Inclusion of at least one prescription medication
Level of seriousness of interaction/serious adverse event associated with the medication
Hypothesis to improve the drug safety profile has a strong scientific basis
Originality – the hypothesis must not have been previously studied or currently addressed on an existing drug label
How well will the proposed clinical/non-clinical research support your hypothesis*
Potential of proposed research to yield clinical impact – how likely will the results change the use of the drug
Note:
Judges will not take into account the feasibility of you or your lab to personally perform the research. They will only consider the merits if the research were to be performed
Finalists will be notified around February 15, 2022
